The Enterprise Value as of November 2024 (TTM) for ChitogenX Inc. (CHNXF) is 4.72M

According to ChitogenX Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.72M. This represents a change of -45.46% compared to the average of 8.65M of the last 4 quarters.

ChitogenX Inc. (CHNXF) Historical Enterprise Value (quarterly & annually)

How has CHNXF Enterprise Value performed in the past?

The mean historical Enterprise Value of ChitogenX Inc. over the last ten years is 13.10M. The current 4.72M Enterprise Value has changed 3.50% with respect to the historical average. Over the past ten years (40 quarters), CHNXF's Enterprise Value was at its highest in in the January 2021 quarter at 23.08M. The Enterprise Value was at its lowest in in the April 2015 quarter at 0.

ChitogenX Inc. (CHNXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ChitogenX Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ChitogenX Inc. (CHNXF) Average Enterprise Value

How has CHNXF Enterprise Value performed in the past?

The current Enterprise Value of ChitogenX Inc. (CHNXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ChitogenX Inc. (CHNXF) Enterprise Value vs. Peers

How is CHNXF’s Enterprise Value compared to its peers?

ChitogenX Inc.’s Enterprise Value is greater than Advanced Proteome Therapeutics Corporation (147.52K), less than Cellectis S.A. (144.28M), less than Biotron Limited (19.45M), less than Bioasis Technologies Inc. (39.52M), less than Ceapro Inc. (15.90M), less than Mymetics Corporation (75.33M), greater than ProtoKinetix, Incorporated (3.94M), less than Statera Biopharma, Inc. (14.43M), less than IMV Inc. (0), less than Forward Pharma A/S (0), greater than Lipella Pharmaceuticals Inc. (117.00), greater than Senti Biosciences, Inc. (-63324300.00), greater than Fennec Pharmaceuticals Inc. (1.62M), less than Monopar Therapeutics Inc. (30.14M), less than Applied Molecular Transport Inc. (113.94M), less than Scopus BioPharma Inc. (81.10M), greater than Magenta Therapeutics, Inc. (-5743713.00), greater than Marizyme, Inc. (-107741.00), greater than Allena Pharmaceuticals, Inc. (-114170976.00), less than null (25.72M), greater than null (-29461000.00),

Build a custom stock screener for ChitogenX Inc. (CHNXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ChitogenX Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ChitogenX Inc. (CHNXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ChitogenX Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.